Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

480

HTML

3564

Figures (1-2)

419

Tables (1-1)

476

Sum=4939

Jan 7, 2008 (publication date) through Oct 31, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jan 7, 2008; 14(1): 64-69
Published online Jan 7, 2008. doi: 10.3748/wjg.14.64

Table 1 Histological findings of the patients

Histological findings			Number of patients	SUV (mean ± SD)	Difference
Pathological stage (TNM)
pT	pN	stage
1	0	IA	1	3.59
1	1	IB	1	3.14
3	0	IIA	8	4.1 ± 0.9	NS
1, 2, 3	1	IIB	8	5.9 ± 4.5	NS
Histological differentiation
Well			7	3.7 ± 0.7	NS
Moderately-poorly			11	5.6 ± 3.6	NS
Lymphatic invasions
Negative			9	5.3 ± 3.9	NS
Positive			9	4.5 ± 2.1	NS
Venous invasions
Negative			6	6.2 ± 5.1	NS
Positive			12	4.4 ± 1.9	NS
Intrapancreatic nerve invasions
Negative			11	4.8 ± 3.5	NS
Positive			7	5.1 ± 2.3	NS

SUV: Standard uptake value; NS: Not significant.

Citation: Wakabayashi H, Nishiyama Y, Otani T, Sano T, Yachida S, Okano K, Izuishi K, Suzuki Y. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. World J Gastroenterol 2008; 14(1): 64-69
URL: https://www.wjgnet.com/1007-9327/full/v14/i1/64.htm
DOI: https://dx.doi.org/10.3748/wjg.14.64